Variation in lymph node examination after esophagectomy for cancer in the United States

Archives of Surgery

Volumn 147, Issue 6, 2012, Pages 505-511

  Merkow, Ryan P ^a,b   Bilimoria, Karl Y ^a   Chow, Warren B ^c,d   Merkow, Justin S ^b   Weyant, Michael J ^b   Ko, Clifford Y ^c,d   Bentrem, David J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COMMUNITY HOSPITAL; CONTROLLED STUDY; DATA BASE; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; GEOGRAPHY; HEALTH CARE QUALITY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OBSERVATIONAL STUDY; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UNITED STATES; UNIVERSITY HOSPITAL;

AGED; BENCHMARKING; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGOGASTRIC JUNCTION; FEMALE; GUIDELINE ADHERENCE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE PERIOD; PRACTICE GUIDELINES AS TOPIC; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84860850096     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.2215     Document Type: Article

References (36)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300.
2. Mariette C, Piessen G, Briez N, Triboulet JP. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008;247(2):365-371.
3. Hofstetter W, Correa AM, Bekele N, et al. Proposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg. 2007;84(2): 365-375.
4. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009.
5. Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721-1724.
6. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
7. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46-50.
8. Senthil M, Trisal V, Paz IB, Lai LL. Prediction of the adequacy of lymph node retrieval in colon cancer by hospital type. Arch Surg. 2010;145(9):840-843.
9. National Comprehensive Cancer Network. Guidelines in oncology: esophageal cancer, V.2.2010. http://www.nccn.org. Accessed October 15, 2010.
10. Commission on Cancer. Cancer program accreditation. http://www.facs.org /cancer/coc/whatis.html. Accessed April 15, 2011.
11. American College of Surgeons. National Cancer Data Base Participant Use Data File. http://www.facs.org/cancer/ncdb/participantuserfiles.html. Accessed April 15, 2011.
12. World Health Organization. International Classification of Disease for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
13. American College of Surgeons. Commission on Cancer Facility Oncology Registry Data Standards, 2003-2011. http://www.facs.org/cancer/ncdb/cocmanuals .html. Accessed April 15, 2011.
14. American College of Surgeons. Commission on Cancer Registry Operations and Data Standards, 1996-2002. http://www.facs.org/cancer/ncdb/cocmanuals .html. Accessed April 15, 2011.
15. Department of Health and Human Services. International Classification of Diseases, Ninth Revision, Clinical Modification. Washington, DC: Government Printing Office; 1998.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
17. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
18. Tomlinson JS, Jain S, Bentrem DJ, et al. Accuracy of staging node-negative pancreas cancer: a potential quality measure. Arch Surg. 2007;142(8):767-774.
19. Bilimoria KY, Bentrem DJ, Stewart AK, et al. Lymph node evaluation as a colon cancer quality measure: a national hospital report card. J Natl Cancer Inst. 2008; 100(18):1310-1317.
20. Hollenbeck BK, Ye Z, Wong SL, Montie JE, Birkmeyer JD. Hospital lymph node counts and survival after radical cystectomy. Cancer. 2008;112(4):806-812.
21. Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24(22):3570-3575.
22. Schwarz RE, Smith DD. Extent of lymph node retrieval and pancreatic cancer survival: information from a large US population database. Ann Surg Oncol. 2006; 13(9):1189-1200.
23. Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large USpopulation database. J Clin Oncol. 2005;23(28):7114-7124.
24. National Quality Forum. At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer. http://www.qualityforum.org /MeasureDetails.aspx?SubmissionId=455. Accessed May 5, 2011.
25. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248(2):221-226.
26. Barbour AP, Rizk NP, Gonen M, et al. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol. 2007;14(2):306-316.
27. Greenstein AJ, Litle VR, Swanson SJ, Divino CM, Packer S, Wisnivesky JP. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112(6):1239-1246.
28. Kang CH, Kim YT, Jeon SH, Sung SW, Kim JH. Lymphadenectomy extent is closely related to long-term survival in esophageal cancer. Eur J Cardiothorac Surg. 2007; 31(2):154-160.
29. Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resection. Ann Surg. 2008;248(4):549-556.
30. Rizk N, Venkatraman E, Park B, Flores R, Bains MS, Rusch V; American Joint Committee on Cancer Staging System. The prognostic importance of the number of involved lymph nodes in esophageal cancer: implications for revisions of the American Joint Committee on Cancer staging system. J Thorac Cardiovasc Surg. 2006;132(6):1374-1381.
31. Schwarz RE, Smith DD. Clinical impact of lymphadenectomy extent in resectable esophageal cancer. J Gastrointest Surg. 2007;11(11):1384-1394.
32. Groth SS, Virnig BA, Whitson BA, et al. Determination of the minimum number of lymph nodes to examine to maximize survival in patients with esophageal carcinoma: data from the Surveillance Epidemiology and End Results database. J Thorac Cardiovasc Surg. 2010;139(3):612-620.
33. Bilimoria KY, Talamonti MS, Wayne JD, et al. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg. 2008; 143(7):671-678.
34. Baxter NN, Tuttle TM. Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol. 2005;12(12):981-987.
35. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97(3):219-225.
36. Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007; 298(18):2149-2154.